de State Street Utah Medical Products UTMD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 4.43 M | Vender |
63,937
-465
| -0.7% | -USD 30.9 k | ﹤0.01% | 3119 |
|
|
2026
Q1 | USD 4.01 M | Vender |
64,402
-3,605
| -5% | -USD 227 k | ﹤0.01% | 3047 |
|
|
2025
Q4 | USD 3.83 M | Vender |
68,007
-2,256
| -3% | -USD 131 k | ﹤0.01% | 3109 |
|
|
2025
Q3 | USD 4.45 M | Comprar |
70,263
+141
| +0.2% | +USD 8.34 k | ﹤0.01% | 3033 |
|
|
2025
Q2 | USD 4.01 M | Vender |
70,122
-10,028
| -13% | -USD 545 k | ﹤0.01% | 3036 |
|
|
2025
Q1 | USD 4.52 M | Vender |
80,150
-2,548
| -3% | -USD 153 k | ﹤0.01% | 2923 |
|
|
2024
Q4 | USD 5.11 M | Comprar |
82,698
+1,842
| +2% | +USD 119 k | ﹤0.01% | 2966 |
|
|
2024
Q3 | USD 5.43 M | Comprar |
80,856
+694
| +0.9% | +USD 47.1 k | ﹤0.01% | 2926 |
|
|
2024
Q2 | USD 5.38 M | Vender |
80,162
-496
| -0.6% | -USD 33.8 k | ﹤0.01% | 2897 |
|
|
2024
Q1 | USD 5.76 M | Comprar |
80,658
+6,331
| +9% | +USD 475 k | ﹤0.01% | 2866 |
|
|
2023
Q4 | USD 6.28 M | Comprar |
74,327
+3,431
| +5% | +USD 285 k | ﹤0.01% | 2846 |
|
|
2023
Q3 | USD 6.12 M | Vender |
70,896
-20
| -0% | -USD 1.85 k | ﹤0.01% | 2832 |
|
|
2023
Q2 | USD 6.63 M | Vender |
70,916
-530
| -0.7% | -USD 49.9 k | ﹤0.01% | 2860 |
|
|
2023
Q1 | USD 6.79 M | Comprar |
71,446
+1,421
| +2% | +USD 131 k | ﹤0.01% | 2868 |
|
|
2022
Q4 | USD 7.06 M | Comprar |
70,025
+390
| +0.6% | +USD 35.6 k | ﹤0.01% | 2879 |
|
|
2022
Q3 | USD 5.96 M | Vender |
69,635
-368
| -0.5% | -USD 32.5 k | ﹤0.01% | 2973 |
|
|
2022
Q2 | USD 6.03 M | Vender |
70,003
-581
| -0.8% | -USD 49.6 k | ﹤0.01% | 3002 |
|
|
2022
Q1 | USD 6.36 M | Comprar |
70,584
+1,650
| +2% | +USD 152 k | ﹤0.01% | 3059 |
|
|
2021
Q4 | USD 6.89 M | Comprar |
68,934
+1,599
| +2% | +USD 163 k | ﹤0.01% | 3096 |
|
|
2021
Q3 | USD 6.27 M | Comprar |
67,335
+1,282
| +2% | +USD 113 k | ﹤0.01% | 3113 |
|
|
2021
Q2 | USD 5.64 M | Vender |
66,053
-3,088
| -4% | -USD 267 k | ﹤0.01% | 3189 |
|
|
2021
Q1 | USD 6.01 M | Vender |
69,141
-8,235
| -11% | -USD 724 k | ﹤0.01% | 2968 |
|
|
2020
Q4 | USD 6.54 M | Comprar |
77,376
+1,630
| +2% | +USD 139 k | ﹤0.01% | 2830 |
|
|
2020
Q3 | USD 6.07 M | Vender |
75,746
-1,041
| -1% | -USD 86.4 k | ﹤0.01% | 2688 |
|
|
2020
Q2 | USD 6.83 M | Comprar |
76,787
+1,008
| +1% | +USD 90.5 k | ﹤0.01% | 2614 |
|
|
2020
Q1 | USD 7.15 M | Vender |
75,779
-1,942
| -2% | -USD 180 k | ﹤0.01% | 2460 |
|
|
2019
Q4 | USD 8.41 M | Comprar |
77,721
+3,716
| +5% | +USD 376 k | ﹤0.01% | 2609 |
|
|
2019
Q3 | USD 7.11 M | Comprar |
74,005
+1,878
| +3% | +USD 175 k | ﹤0.01% | 2622 |
|
|
2019
Q2 | USD 6.92 M | Vender |
72,127
-552
| -0.8% | -USD 46.5 k | ﹤0.01% | 2659 |
|
|
2019
Q1 | USD 6.44 M | Vender |
72,679
-22,938
| -24% | -USD 2.02 M | ﹤0.01% | 2641 |
|
|
2018
Q4 | USD 7.97 M | Vender |
95,617
-498
| -0.5% | -USD 43.8 k | ﹤0.01% | 2528 |
|
|
2018
Q3 | USD 9.05 M | Comprar |
96,115
+4,928
| +5% | +USD 471 k | ﹤0.01% | 2594 |
|
|
2018
Q2 | USD 10 M | Comprar |
91,187
+2,429
| +3% | +USD 254 k | ﹤0.01% | 2539 |
|
|
2018
Q1 | USD 8.78 M | Vender |
88,758
-439
| -0.5% | -USD 39.2 k | ﹤0.01% | 2524 |
|
|
2017
Q4 | USD 7.26 M | Comprar |
89,197
+411
| +0.5% | +USD 32.1 k | ﹤0.01% | 2625 |
|
|
2017
Q3 | USD 6.53 M | Comprar |
88,786
+9,404
| +12% | +USD 676 k | ﹤0.01% | 2661 |
|
|
2017
Q2 | USD 5.75 M | Comprar |
79,382
+6,925
| +10% | +USD 456 k | ﹤0.01% | 2671 |
|
|
2017
Q1 | USD 4.51 M | Vender |
72,457
-1,159
| -2% | -USD 73 k | ﹤0.01% | 2757 |
|
|
2016
Q4 | USD 5.36 M | Comprar |
73,616
+5,204
| +8% | +USD 338 k | ﹤0.01% | 2659 |
|
|
2016
Q3 | USD 4.09 M | Comprar |
68,412
+2,796
| +4% | +USD 178 k | ﹤0.01% | 2671 |
|
|
2016
Q2 | USD 4.13 M | Comprar |
65,616
+6,110
| +10% | +USD 394 k | ﹤0.01% | 2702 |
|
|
2016
Q1 | USD 3.72 M | Comprar |
59,506
+4,855
| +9% | +USD 286 k | ﹤0.01% | 2711 |
|
|
2015
Q4 | USD 3.2 M | Comprar |
54,651
+3,993
| +8% | +USD 226 k | ﹤0.01% | 2778 |
|
|
2015
Q3 | USD 2.73 M | Comprar |
50,658
+2,399
| +5% | +USD 131 k | ﹤0.01% | 2852 |
|
|
2015
Q2 | USD 2.88 M | Comprar |
48,259
+422
| +0.9% | +USD 23.8 k | ﹤0.01% | 2915 |
|
|
2015
Q1 | USD 2.87 M | Comprar |
47,837
+815
| +2% | +USD 47.9 k | ﹤0.01% | 2874 |
|
|
2014
Q4 | USD 2.82 M | Comprar |
47,022
+1,205
| +3% | +USD 66.7 k | ﹤0.01% | 2887 |
|
|
2014
Q3 | USD 2.24 M | Comprar |
45,817
+301
| +0.7% | +USD 15.3 k | ﹤0.01% | 2964 |
|
|
2014
Q2 | USD 2.34 M | Comprar |
45,516
+65
| +0.1% | +USD 3.34 k | ﹤0.01% | 2994 |
|
|
2014
Q1 | USD 2.63 M | Comprar |
45,451
+228
| +0.5% | +USD 12.4 k | ﹤0.01% | 2932 |
|
|
2013
Q4 | USD 2.58 M | Vender |
45,223
-1,142
| -2% | -USD 62.7 k | ﹤0.01% | 2944 |
|
|
2013
Q3 | USD 2.76 M | Comprar |
46,365
+655
| +1% | +USD 35.7 k | ﹤0.01% | 2882 |
|
|
2013
Q2 | USD 2.48 M | Comprar |
+45,710
| Nuevas | +USD 2.15 M | ﹤0.01% | 2860 |
|
Otros fondos que tienen UTMD en su cartera
MA
Posición de State Street en UTMD: resumen de T2 2026
State Street redujo su participación en Utah Medical Products (UTMD) en 0.72% durante T2 2026, al vender acciones por un valor estimado de USD 30.9 k, y conservó 63,937 acciones valuadas en USD 4.43 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #3119.
State Street reportó por primera vez una posición en UTMD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 10 M en T2 2018. Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank mantienen una posición en UTMD.
- Al cierre de T2 2026, State Street tenía 63,937 acciones de Utah Medical Products con un valor de USD 4.43 M.
- State Street vendió 465 acciones de Utah Medical Products en T2 2026, por un valor estimado de USD 30.9 k.
- Utah Medical Products representó ﹤0.01% de la cartera de State Street en T2 2026 y fue su posición número 3119.
- State Street reportó por primera vez una posición en Utah Medical Products en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de State Street en Utah Medical Products alcanzó su máximo de USD 10 M en T2 2018.
- Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank tenían Utah Medical Products en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.